These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 22149)

  • 1. [Equilibrium system consisting of soluble forms of fibrin and the specific anticoagulant D fragment of the firbinogen molecule].
    Smekhova KO; Ugarova TP; Pozdniakova TM; Belitser VO
    Ukr Biokhim Zh; 1977; 49(6):5-11. PubMed ID: 22149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative determination of protector activity of fibrinogen tryptic hydrolysates].
    Musialkivs'ka AO; Pozdniakova TM; Platonova TM; Khomenko VM
    Ukr Biokhim Zh; 1977; 49(4):118-23. PubMed ID: 19861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of the fragment D-fibrin monomer complex formation by salting-out fractionation].
    Pozdniakova TM; Rybachuk VN; Vovk Ev
    Biokhimiia; 1982 Jun; 47(6):971-6. PubMed ID: 7115809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies in the fibrinogen molecule D fragment inactivation protecting fragment].
    Uharova TP; Smekhova KO; Musjalkivs'ka AO
    Ukr Biokhim Zh; 1977; 49(5):60-3. PubMed ID: 919058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of the formation of complexes between monomer fibrin and the inhibitor of its polymerization - fragment D].
    Belitser VA; Pozdniakova TM; Vovk EV; Rybachuk VN
    Biokhimiia; 1983 Jan; 48(1):125-31. PubMed ID: 6830911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibition of fibrin assembly by fragment D and its dimer derived from fibrinogen and stabilized fibrin. Evidence for the two-step type of inhibition].
    Platonova TN; Musialkovskaia AA; Tolstykh VM; Belitser VA
    Biokhimiia; 1980 Oct; 45(10):1780-7. PubMed ID: 7236767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Properties of 2 fibrin monomer forms which differ in the degree of thrombin activation. Relation of these 2 forms to specific polymerization inhibitors].
    Lugovskoi EV; Tsariuk LA; Gogolinskaia GK; Derzskaia SG; Belitser VA
    Biokhimiia; 1978 Jul; 43(7):1162-6. PubMed ID: 698303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The receptor for the globular "heads" of C1q, gC1q-R, binds to fibrinogen/fibrin and impairs its polymerization.
    Lu PD; Galanakis DK; Ghebrehiwet B; Peerschke EI
    Clin Immunol; 1999 Mar; 90(3):360-7. PubMed ID: 10075865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modification of fibrin assembly as a method for studying the mechanism of this process].
    Belitser VO; Varetska TV
    Ukr Biokhim Zh; 1975; 47(5):567-79. PubMed ID: 1202701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN.
    Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanism of self-assembly of soluble fibrin oligomers and the role of fibrinopeptides A and B in this process].
    Rozenfel'd MA; Gershkovich KB; Kuznetsov DV; Meshkov BB; Gontar' ID
    Mol Biol (Mosk); 1986; 20(4):1098-110. PubMed ID: 3762532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of fibrin network ultrastructure by Fab fragments specific for different domain of fibrinogen.
    Cierniewski CS; Janiak A; Wyroba E
    Acta Biochim Pol; 1986; 33(3):195-202. PubMed ID: 2433859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of inhibition of fibrin polymerization by fibrinogen and its active fragments].
    Belitser VA; Varetskaia TV; Kosterin SA
    Biokhimiia; 1980 Jan; 45(1):157-64. PubMed ID: 7213830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biologically active low-molecular fragments of fibrinogen molecule].
    Musialkivs'ka AO; Platonova TM; Radavs'kiĭ IuL
    Ukr Biokhim Zh; 1977; 49(3):89-93. PubMed ID: 888231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amino acids that constitute sequence gamma 268-282 of fibrinogen are not involved in fibrin monomer polymerization.
    Janiak A; Plucinski T; Kupryszewski G; Cierniewski CS
    Acta Biochim Pol; 1993; 40(4):515-20. PubMed ID: 8140826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin.
    Spraggon G; Everse SJ; Doolittle RF
    Nature; 1997 Oct; 389(6650):455-62. PubMed ID: 9333233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Electrophoretic fractions and NH2-terminal amino acids of high-molecular tryptic fragments of fibrinogen and fibrin].
    Lugovskoĭ EV; Pozdniakova TM; Varetskaia TV; Derzskaia SG; Tolstykh VM
    Ukr Biokhim Zh; 1976; 48(6):743-9. PubMed ID: 1014141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fibrin-fragment D-protector equilibrium system. Quantitative determination of protector activity].
    Ugarova TP; Belitser VA
    Ukr Biokhim Zh (1978); 1978; 50(3):357-63. PubMed ID: 664050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The study of fibrin polymerization with monoclonal antibodies.
    Lugovskoi EV; Makogonenko EM; Chudnovets VS; Derzskaya SG; Gogolinskaya GK; Kolesnikova IN; Bukhanevich AM; Sitak IN; Lyashko ED; Komissarenko SV
    Biomed Sci; 1991; 2(3):249-56. PubMed ID: 1751757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.